《Table 5.Secondary Treatment Outcomes of RUTI Patients[Case (%) ]》

《Table 5.Secondary Treatment Outcomes of RUTI Patients[Case (%) ]》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Treatment of Uncomplicated Recurrent Urinary Tract Infection with Chinese Medicine Formula: A Randomized Controlled Trial》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

At the end of the treatment，the uropathogen was cleared in 53（88.3%）of the CM patients，which was higher than observed in the antibiotics group at 47（77.0%）patients.Only 2 patients in the CM group and8 patients in the antibiotics group showed a decreased concentration（102 to<105 CFU/mL）of uropathogens in the urine（Table 5）.Therefore，in most cases，the bacteria were cleared from the patients.The CM group showed greater bacterial clearance than the antibiotics group，although this difference was not significant.In all three methods of ITT，PP，and NRT，the clearance rates were greater than 80%，and it was slightly higher in the CM group than that in the antibiotics group；however，no significant difference was observed between the two groups in any of the three analytical methods（P>0.05）.

图表编号XD0049341200    严禁用于非法目的
绘制时间2019.01.01
作者LIU Shi-wei、GUO Jie、WU Wei-kang、CHEN Ze-liang、ZHANG Ning
绘制单位Department of Nephrology and Endocrinology, Wangjing Hospital, Chinese Academy of Chinese Medical Science、Department of Nephrology and Endocrinology, Wangjing Hospital, Chinese Academy of Chinese Medical Science、Institute of Integrative Medicine, Sun Yat-
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  2. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  3. 《Table 1 Peer-reviewed literature reports on the clinical outcomes of patients undergoing percutaneous catheter drainage》2019.04.27
  4. 《Table 4.Primary Treatment Outcomes of RUTI Patients[Case (%) ]》2019.01.01
  5. 《Table 2.Treatment, outcome and survival time of 13 induction-therapeutic patients》2019.02.20
  6. 《Table 3.Comparison of SIT between different groups of patients before and after treatment》2019.01.01
  7. 《Table 2.Comparison of BUT between different groups of patients before and after treatment》2019.01.01
  8. 《Table 5 Comparison of surgical outcomes between patients with absent and present SNAP》2019.03.01
  9. 《Table 3 Pregnancy outcomes of patients in h-FSH/n-E2and h-FSH/h-E2groupsa)》2019.01.05
  10. 《Table 1 Baseline parameters and pregnancy outcomes of patients in n-FSH and h-FSH groupsa)》2019.01.05
  11. 《Table 2 Pregnancy outcomes of patients in n-FSH/n-E2and n-FSH/h-E2groupsa)》2019.01.05
  12. 《Table 2Treatment outcomes (n=44) .》2019.02.15
  13. 《Table 1Baseline characteristics and procedural outcomes of patients who underwent EUS-TD for PCs due to AP.》2019.02.15
  14. 《Table 1:Baseline characteristics of patients receiving placebo treatment compared between Asian population and Caucasian》2018.07.05
  15. 《Table 1 Characteristics of patients reported in the literature and our case》2018.11.01
  16. 《Table 3 Surgical outcomes of patients with infantile esotropia who underwent bilateral medial rectus muscle recession be》2018.12.18
  17. 《Table 2Clinical outcomes of enrolled patients.》2018.12.15
  18. 《Table 2Surgical outcomes of patients who underwent ABO-I LDLT.》2018.04.01
  19. 《Table 3Postoperative outcomes of the study patients.》2018.02.01
  20. 《表4 两组患者末次随访时观察指标的比较Tab.4 Secondary outcomes of patients in the two groups at 6months post-treatment (Mean±SD)》2018.02.20

随机翻阅

《表2 焊接试验参数：吐哈油田雁木西大井眼盐膏层水平井钻井技术应用》 《表3 哈尔滨市第64中学“好书分享，畅游书海”学生读书推介会一览表》 《表1 7#燃烧器一次风速变化情况》 《表1 感应加热与电阻炉加热性能对比》 《表8 政府引导基金的“风险分担效应”》 《表1 引物序列：蠲痹历节清方对痛风细胞模型中PPARγ、TLR4、NF-κB的影响》 《表1 细胞毒化疗药物处方审核点》 《表1 实践活动要求质量水平表》 《表2 随机点赋值后各要素层与综合状况Spearman秩相关系数》 《表1 前5个最大小波系数对应方向分量的参数》